Gilde Healthcare Revenue and Competitors

Utrecht, Netherlands



Total Funding



Estimated Revenue & Valuation

  • Gilde Healthcare's estimated annual revenue is currently $11.1M per year.(i)
  • Gilde Healthcare's estimated revenue per employee is $197,490
  • Gilde Healthcare's total funding is $42M.

Employee Data

  • Gilde Healthcare has 56 Employees.(i)
  • Gilde Healthcare grew their employee count by 4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. Gilde Healthcare's lower mid-market buy-out fund invests in profitable European healthcare services companies with a focus on the Netherlands, Belgium and Germany. The portfolio consists of healthcare providers, suppliers of medical products and other service providers in the healthcare market. Gilde Healthcare's venture & growth capital fund invests in medtech, diagnostics, digital health and therapeutics. The portfolio companies are based in Europe and North America. Since 2001 Gilde Healthcare has raised 800 million ($900 million) for its specialized funds.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Gilde Healthcare News

2022-04-19 - Big Health, CVS launch medication targeting program

ArrowMark Partners entered as a new investor, joined by existing investors Octopus Ventures, Gilde Healthcare, Kaiser Permanente Ventures...

2022-03-22 - Gilde Healthcare Closes Gilde Healthcare Private Equity IV, At ...

The Gilde Healthcare Private Equity IV fund targets companies with an EBITDA of €2 to €15 million. Recent examples of private equity investments...

2021-07-14 - Spire Health closes $38 million financing round led by Gilde Healthcare to advance respiratory remote patient monitoring

San Francisco (California, US) & Cambridge (Massachusetts, US) – Spire Health, the leading provider of respiratory remote patient monitoring (RPM), today announced the closing of a $38 million equity financing, led by Gilde Healthcare Partners along with a leading global medtech strategic partne ...

2021-03-17 - Amphista Therapeutics raises $53M in Series B round co-led by Gilde Healthcare to advance next generation targeted protein degradation assets

Glasgow, UK - Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the closing of a $53 million (£38 million) Series B financing round from an investor syndicate co-led by Gilde Healthcare. The proceeds will be used to accelerate the c ...

2021-01-06 - Gilde Healthcare leads $28 million financing in Volta Medical to revolutionize persistent AFib ablation

Marseille (France) - Utrecht (the Netherlands) – Volta Medical, a French-based HealthTech startup, pioneering novel artificial intelligence (AI) algorithms to treat cardiac arrythmias, today announced that it has successfully raised an 28 million USD financing round led by Gilde Healthcare. The ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding